In vivo therapy with monoclonal anti-I-A antibody suppresses immune responses to acetylcholine receptor
- 1 May 1983
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 80 (9), 2713-2717
- https://doi.org/10.1073/pnas.80.9.2713
Abstract
A monoclonal antibody to I-A gene products of the immune response gene complex attenuates both humoral and cellular responses to acetylcholine receptor and appears to suppress clinical manifestations of experimental autoimmune myasthenia gravis. This demonstrates that use of antibodies against immune response gene products that are associated with susceptibility to disease may be feasible for therapy in autoimmune conditions such as myasthenia gravis.Keywords
This publication has 29 references indexed in Scilit:
- Conversion of immunity to suppression by in vivo administration of I-A subregion-specific antibodies.The Journal of Experimental Medicine, 1982
- Properties of Monoclonal Antibodies to Mouse Ig Allotypes, H-2, and Ia AntigensPublished by Springer Nature ,1979
- Induction of anti-idiotypic antibodies by immunisation with syngeneic spleen cells educated with acetylcholine receptorNature, 1978
- Plasmapheresis and Immunosuppressive Drug Therapy in Myasthenia GravisNew England Journal of Medicine, 1977
- Reduction of syngeneic tumor growth by an anti-I-J-alloantiserum.Proceedings of the National Academy of Sciences, 1977
- Modulation of acetylcholine receptor by antibody against the receptorProceedings of the National Academy of Sciences, 1977
- Myasthenic Immunoglobulin Accelerates Acetylcholine Receptor DegradationScience, 1977
- Effect of sodium salicylate on human and mouse granulopoiesis in vitroArthritis & Rheumatism, 1977
- Strain differences in the autoimmune response of mice to acetylcholine receptorsNature, 1976
- A simple assay for the study of solubilized acetylcholine receptorsAnalytical Biochemistry, 1973